PD L1 News and Research

RSS
FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

Non-small cell lung cancer patients survive longer when treated with durvalumab

Non-small cell lung cancer patients survive longer when treated with durvalumab

Organs actively fighting back against autoimmune diseases, finds study

Organs actively fighting back against autoimmune diseases, finds study

Immune checkpoint inhibition may be effective in treating HIV-associated Kaposi's sarcoma

Immune checkpoint inhibition may be effective in treating HIV-associated Kaposi's sarcoma

Researchers test experimental cancer vaccine on mice with aggressive melanoma

Researchers test experimental cancer vaccine on mice with aggressive melanoma

Researchers discover reason why many bladder cancer patients do not respond to immunotherapy

Researchers discover reason why many bladder cancer patients do not respond to immunotherapy

New radiomic signature offers predictive score for efficacy of immunotherapy in patients

New radiomic signature offers predictive score for efficacy of immunotherapy in patients

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

Cancer cells release biological 'drones' to assist in the fight against immune system

Cancer cells release biological 'drones' to assist in the fight against immune system

Blood-based test accurately identifies lung cancer patients who could benefit from immunotherapies

Blood-based test accurately identifies lung cancer patients who could benefit from immunotherapies

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Scientists identify melanoma biomarkers that could help tailor immunotherapy treatments

Scientists identify melanoma biomarkers that could help tailor immunotherapy treatments

New clinical trial to evaluate virotherapy and immunotherapy combination for ovarian, colorectal cancers

New clinical trial to evaluate virotherapy and immunotherapy combination for ovarian, colorectal cancers

Study uncovers process that neutralizes tumor cells

Study uncovers process that neutralizes tumor cells

Researchers find new marker for better prognosis in gastric and esophageal cancer

Researchers find new marker for better prognosis in gastric and esophageal cancer

Research shows why new cancer therapies fail to work on some patients

Research shows why new cancer therapies fail to work on some patients

Ocular oncologists link immunotherapy with potentially vision-robbing side effect

Ocular oncologists link immunotherapy with potentially vision-robbing side effect

New study evaluates expression of PD-L1 in human medulloblastoma

New study evaluates expression of PD-L1 in human medulloblastoma

New vaccine strategy increases number of tumor-specific cancer-killing T cells

New vaccine strategy increases number of tumor-specific cancer-killing T cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.